PTC Therapeutics, Inc. (PTCT) financial statements (2021 and earlier)

Company profile

Business Address 100 CORPORATE COURT
SOUTH PLAINFIELD, NJ 07080-2449
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,104687228191232339315
Cash and cash equivalents209288169112585850
Short-term investments8953995879173281265
Receivables7056684025114
Inventory, net of allowances, customer advances and progress billings191916112  
Inventory191916112  
Other undisclosed current assets391897364
Total current assets:1,232779321249261356324
Noncurrent Assets
Operating lease, right-of-use asset8414
Property, plant and equipment3422138799
Intangible assets, net (including goodwill)798793783133   
Goodwill828282    
Intangible assets, net (excluding goodwill)715711701133   
Regulated entity, other noncurrent assets     3 
Other undisclosed noncurrent assets611621100
Total noncurrent assets:97784479814381210
TOTAL ASSETS:2,2081,6241,119392269368333
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:24215912876494529
Accounts payable19106156124
Accrued liabilities3013224486
Employee-related liabilities5339281814119
Taxes payable4      
Other undisclosed accounts payable and accrued liabilities13697733925149
Deferred revenue48
Debt12512    
Deferred revenue and credits4 03
Contract with customer, liability4
Other liabilities18421  
Other undisclosed current liabilities283519    
Total current liabilities:27723616782504532
Noncurrent Liabilities
Long-term debt and lease obligation4122941411459895 
Long-term debt, excluding current maturities3092941411459895 
Finance lease, liability23 
Operating lease, liability79 
Liabilities, other than long-term debt3795004428222
Deferred revenue and credits82  
Deferred revenue 3
Contract with customer, liability10
Deferred tax liabilities, net122    
Deferred income tax liabilities137131
Other liabilities1900022
Business combination, contingent consideration, liability240356310    
Other undisclosed noncurrent liabilities659 18    
Total noncurrent liabilities:1,449794602153100972
Total liabilities:1,7261,02976823515014235
Stockholders' equity
Stockholders' equity attributable to parent482594351156120226298
Common stock0000000
Additional paid in capital2,1721,7951,288967856820722
Accumulated other comprehensive income (loss)(61)(11)14(1)(1)(1)
Accumulated deficit(1,629)(1,190)(939)(814)(735)(593)(423)
Total stockholders' equity:482594351156120226298
TOTAL LIABILITIES AND EQUITY:2,2081,6241,119392269368333

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues381307265194833725
Revenue, net194833725
Cost of revenue
(Cost of Goods and Services Sold)
(1)(12)(2)(5)   
Gross profit:380295263190833725
Operating expenses(813)(548)(380)(259)(215)(204)(125)
Other undisclosed operating income11225   
Operating loss:(432)(241)(116)(64)(132)(167)(99)
Nonoperating income (expense)142250(1)(1)(0)(0)
Foreign currency transaction gain, before tax571200   
Other nonoperating income (expense)85140(1)(1)(0)(0)
Interest and debt expense(1)(1)(1)(0)(0)(0) 
Other undisclosed loss from continuing operations before equity method investments, income taxes(112)(23)(12)(12)   
Loss from continuing operations before equity method investments, income taxes:(403)(240)(128)(78)(134)(168)(100)
Other undisclosed income (loss) from continuing operations before income taxes    (8)(2)1
Loss from continuing operations before income taxes:(403)(240)(128)(78)(142)(170)(98)
Income tax expense (benefit)(35)(12)0(1)(1)(0)5
Net loss available to common stockholders, diluted:(438)(252)(128)(79)(142)(170)(94)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(438)(252)(128)(79)(142)(170)(94)
Other comprehensive income (loss) (12)(3)5 (0)(1)
Comprehensive loss:(438)(264)(131)(74)(142)(171)(94)
Other undisclosed comprehensive loss, net of tax, attributable to parent(50)   (0) (0)
Comprehensive loss, net of tax, attributable to parent:(489)(264)(131)(74)(142)(171)(95)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: